Skip to main content
. Author manuscript; available in PMC: 2024 Jan 31.
Published in final edited form as: J Health Econ. 2018 Jul 26;61:111–133. doi: 10.1016/j.jhealeco.2018.06.012

Table A.9.

Provider price responses to reference pricing: full insured population denominator.

Arthroscopy Cataract Colonoscopy



(1) (2) (3) (4) (5) (6)
ASC HOPD ASC HOPD ASC HOPD

Post × ln(CalPERS exposure) −0.0251 −0.0135 −0.0733* −0.0112 −0.0403 −0.0203
(0.0474) (0.0302) (0.0427) (0.0170) (0.0265) (0.0236)
2010 0.0156 0.0843*** 0.0141 0.0895*** 0.0237*** 0.0744***
(0.0126) (0.00881) (0.0129) (0.00854) (0.00722) (0.0101)
2011 0.111*** 0.152*** 0.0421* 0.160*** 0.0579*** 0.140***
(0.0177) (0.0107) (0.0245) (0.0105) (0.0109) (0.0125)
2012 0.148*** 0.230*** 0.0986*** 0.212*** 0.143*** 0.224***
(0.0327) (0.0295) (0.0367) (0.0153) (0.0278) (0.0168)
2013 0.186*** 0.272*** 0.146** 0.271*** 0.181*** 0.244***
(0.0297) (0.0310) (0.0639) (0.0187) (0.0287) (0.0210)
Observations 46,696 21,874 20,062 5836 224,469 86,585
Number of providers 325 242 238 153 414 274
Number of markets 108 104 109 74 117 113
Adjusted R2 0.259 0.211 0.184 0.283 0.255 0.177
Mean price 4409 7894 1882 6559 1067 2772

This table presents the results from Eq. (1) and estimates provider price responses to the CalPERS reference pricing program, but measures CalPERS exposure relative to the entire insured population (commercially insured, Medicare, and Medicaid). The odd-numbered columns restrict the sample to ASC providers and the even-numbered columns restrict the sample to HOPD providers. The dependent variable inall columns is ln(priceijtk) and each regression is estimated using OLS. Controls for month, patient age, gender, Charlson comorbidity score, indicators for 17 chronic conditions, and patient HRR fixed effects are included but not reported. Robust standard errors clustered at the Hospital Service Area level are in parentheses.

***

p < 0.01.

**

p < 0.05.

*

p < 0.1.